(Q47794847)

5 February 2018

title

Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells (English)

1 reference

5 February 2018

0 references

1 reference

3

1 reference

5 February 2018

Hideho Okada

6

object named as

Hideho Okada

1 reference

5 February 2018

author name string

Norimoto Nakahara

1

1 reference

5 February 2018

Ian F Pollack

2

1 reference

5 February 2018

Toshihiko Wakabayashi

4

1 reference

5 February 2018

Jun Yoshida

5

1 reference

5 February 2018

publication date

1 July 2003

1 reference

5 February 2018

published in

Cancer Gene Therapy

1 reference

5 February 2018

volume

10

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

549-558

1 reference

5 February 2018

Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Effectiveness of Interferon-β, ACNU, and Radiation Therapy in Pediatric Patients with Brainstem Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Dendritic cells: On the move from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Quantitative analysis of exocytosis directly visualized in living chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Process of apoptosis induced by TNF-alpha in murine fibroblast Ltk-cells: continuous observation with video enhanced contrast microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Interleukin-12 and its role in the generation of TH1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Brain dendritic cells and macrophages/microglia in central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Growth inhibition of human glioma cells by superinduced human interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

A weak signal for strong responses: interferon-alpha/beta revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Developmental plasticity of CNS microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Microglia induce CD4 T lymphocyte final effector function and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Microglia only weakly present glioma antigen to cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Combination of stereotactic radiosurgery and cytokine gene-transduced tumor cell vaccination: a new strategy against metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700598

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700598

1 reference

5 February 2018

1 reference

5 February 2018